TheraRadar
← Back
Data updated: Mar 29, 2026

WEST-WARD PHARMS INT

OncologyGastroenterologyInfectious Disease
Generics

WEST-WARD PHARMS INT is a generic drug manufacturer focused on Oncology, Gastroenterology, Infectious Disease.

1971
Since
16
Drugs
-
Trials
165
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
BUMETANIDE 2026-02-05
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
2 drugs
Gastroenterology 33%
2 drugs
Infectious Disease 17%
1 drugs
Cardiovascular 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular
WAYLIS THERAP big-pharma
Oncology, Cardiovascular, Infectious Disease, Gastroenterology